Mineralys Therapeutics Posts Q2 Financial Results, Updates on Clinical Trials
RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) this week announced its financial results for the second quarter ending June 30, 2024, and provided a corporate update, highlighting significant progress …
Mineralys Therapeutics Posts Q2 Financial Results, Updates on Clinical Trials Read More